-(-%)

Last update at

Day Range

LowHigh

52 Week Range

LowHigh

Fundamentals

Previous Close -
Market Cap-
Volume
P/E Ratio-
Dividend Yield-%
Revenue TTM-
Revenue Per Share TTM-
Gross Profit TTM -
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Clinuvel Pharmaceuticals Limited's (ASX:CUV) largest shareholders are retail investors with 59% ownership, institutions own 20%
Mon 27 Nov 23, 08:01 PM
Declining Stock and Solid Fundamentals: Is The Market Wrong About Clinuvel Pharmaceuticals Limited (ASX:CUV)?
Thu 02 Nov 23, 02:20 AM
Clinuvel Pharmaceuticals (ASX:CUV) shareholders have endured a 38% loss from investing in the stock three years ago
Fri 06 Oct 23, 12:26 AM
A Look At The Fair Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Tue 27 Jun 23, 03:06 AM
Could The Market Be Wrong About Clinuvel Pharmaceuticals Limited (ASX:CUV) Given Its Attractive Financial Prospects?
Wed 03 May 23, 08:28 PM
Institutions own 21% of Clinuvel Pharmaceuticals Limited (ASX:CUV) shares but individual investors control 54% of the company
Mon 17 Apr 23, 12:11 AM
Clinuvel Pharmaceuticals (ASX:CUV) shareholders have earned a 14% CAGR over the last five years
Thu 30 Mar 23, 09:34 PM
Here's Why We Think Clinuvel Pharmaceuticals (ASX:CUV) Might Deserve Your Attention Today
Tue 14 Mar 23, 11:19 PM
CLINUVEL Launches CYACÊLLE, Next Generation Solar Care
Tue 28 Feb 23, 11:58 PM
Analysts Just Slashed Their Clinuvel Pharmaceuticals Limited (ASX:CUV) EPS Numbers
Tue 28 Feb 23, 10:03 PM

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown

Breakdown

Breakdown

Peer Comparison

Sector: Industry:

Company	Change ()	Price ()	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)

Reports Covered

View All

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.